Vycor Medical, Inc.
VYCO
$0.175
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 496.40K | 436.40K | 455.20K | 390.90K | 406.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 496.40K | 436.40K | 455.20K | 390.90K | 406.30K |
| Cost of Revenue | 81.10K | 77.80K | 57.80K | 36.80K | 35.20K |
| Gross Profit | 415.30K | 358.50K | 397.40K | 354.10K | 371.10K |
| SG&A Expenses | 345.00K | 350.70K | 356.50K | 367.90K | 337.80K |
| Depreciation & Amortization | 14.90K | 14.90K | 14.90K | 14.90K | 14.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 445.20K | 449.20K | 435.90K | 426.00K | 390.10K |
| Operating Income | 51.10K | -12.80K | 19.30K | -35.10K | 16.20K |
| Income Before Tax | 25.70K | -38.50K | -6.70K | -59.80K | -10.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 25.70K | -38.50K | -6.70K | -59.80K | -10.00K |
| Earnings from Discontinued Operations | -1.80K | 0.00 | -100.00 | 0.00 | 0.00 |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.90K | -38.60K | -6.70K | -59.80K | -10.00K |
| EBIT | 51.10K | -12.80K | 19.30K | -35.10K | 16.20K |
| EBITDA | 66.20K | 3.30K | 36.20K | -19.40K | 31.90K |
| EPS Basic | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 33.37M | 33.37M | 33.38M | 32.90M | 32.63M |
| Average Diluted Shares Outstanding | 38.67M | 33.37M | 33.38M | 32.90M | 32.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |